Krystal Biotech (KRYS) Property, Plant & Equipment (Net) Growth (3y) (2019 - 2026)
Krystal Biotech (KRYS) Property, Plant & Equipment (Net) Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | -9.89% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 21.04% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 13.10% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 10.71% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Krystal Biotech | 9.84 Bn | 9.02 Bn | 110.08 Mn | -1.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.98% |
| Dec 31, 2025 | -2.30% |
| Sep 30, 2025 | -1.92% |
| Jun 30, 2025 | -0.18% |
| Mar 31, 2025 | 3.33% |
| Dec 31, 2024 | 11.36% |
| Sep 30, 2024 | 25.81% |
| Jun 30, 2024 | 52.28% |
| Mar 31, 2024 | 67.77% |
| Dec 31, 2023 | 73.48% |
| Sep 30, 2023 | 110.80% |
| Mar 31, 2023 | 151.39% |
| Dec 31, 2022 | 167.20% |
| Sep 30, 2022 | 184.35% |
| Jun 30, 2022 | 193.83% |
| Mar 31, 2022 | 215.65% |
| Dec 31, 2021 | 234.05% |
| Sep 30, 2021 | 263.90% |
| Jun 30, 2021 | 460.06% |
| Mar 31, 2021 | 471.00% |